ABC | Volume 113, Nº6, Dezembro 2019

Artigo Original Calça et al. Reparo da válvula aórtica e função renal Arq Bras Cardiol. 2019; 113(6):1104-1111 1. Bright R. Cases and observations illustrative of renal disease accompanied with the secretion of albuminous urina. Guy’s Hosp Trans. 1986;1:338–79. 2. Keleş T, Ayhan H, Durmaz T, Sarş C, Aslan AN, Erdoğan KE, et al. Improvement in renal functions with transcatheter aortic valve implantation. J Geriatr Cardiol. 2013;10(4):317–22. 3. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus Surgical Aortic-Valve Replacement inHigh-Risk Patients Craig. N Engl J Med. 2011;364(23):2187–98. 4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med. 2010;363(17):1597–607. 5. Florath I, Albert A, Hassanein W, Arnrich B, Rosendahl U, Ennker IC, et al. Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters. Eur J Cardio- thoracic Surg. 2006;30(5):716–21. 6. Anderson RJ, O’Brien M, MaWhinney S, VillaNueva CB, Moritz TE, Sethi GK, et al. Mild renal failure is associatedwith adverse outcome after cardiac valve surgery. Am J Kidney Dis. 2000;35(6):1127–34. 7. Brown JR, Hisey WM, Marshall EJ, Likosky DS, Nichols EL, Everett AD, et al. Acute Kidney Injury Severity and Long-term Readmission and Mortality Following Cardiac Surgery. Ann Thorac Surg. 2016;102(5):1482–9. 8. Elhmidi Y, Bleiziffer S, Deutsch MA, Krane M, Mazzitelli D, Lange R, et al. Acute kidney injury after transcatheter aortic valve implantation: Incidence, predictorsand impactonmortality.ArchCardiovascDis.2014;107(2):133–9. 9. Sinning JM, Ghanem A, Steinhuser H, Adenauer V, Hammerstingl C, Nickenig G, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3(11):1141–9. 10. SarnakMJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, HammLL, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42(5):1050–65. 11. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJL, Mann JF, et al. Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52. 12. Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: New insights intoanoldphenomenon.Hypertension.2006;47(6):1027–34. 13. National Fundation Kidney, KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Am J Kidney Dis.2012;60(5):850-86. 14. Faillace BLR, Ribeiro HB, Campos CM, Truffa AAM, Bernardi FL, Oliveira MDP, et al. Potential of transcatheter aortic valve replacement to improve post-procedure renal function. Cardiovasc Revascularization Med. 2017;18(7):507–11. 15. Azarbal A, Malenka DJ, Huang Y-L, Ross CS, Solomon RJ, DeVries JT, et al. Recovery of Kidney Disfunction After Transcatheter Aortic Valve Implantation (from theNorthernNewEnglandCardiovascular Disease Study Group). Am J Cardiol. 2018;123(1):426-33. 16. Najjar M, Yerebakan H, Sorabella RA, Guglielmetti L, Vandenberge J, Kurlansky P, et al. Reversibility of chronic kidney disease and outcomes following aortic valve replacement. Interact Cardiovasc Thorac Surg. 2015;21(4):499–505. 17. Levi A, Codner P, Masalha A, GargiuloG, Praz F, Hayashida K, et al. Predictors of 1-Year Mortality After Transcatheter Aortic Valve Implantation in Patients With and Without Advanced Chronic Kidney Disease. Am J Cardiol. 2017;120(11):2025–30. 18. Thourani VH, Keeling WB, Sarin EL, Guyton RA, Kilgo PD, Dara AB, et al. Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement. Ann Thorac Surg [Internet]. 2011;91(6):1798–806. 19. Gibson PH, Croal BL, Cuthbertson BH, ChiwaraM, Scott AE, Buchan KG, et al. The relationship between renal function and outcome from heart valve surgery. AmHeart J. 2008;156(5):893–9. 20. Hansen JW, Foy A, Yadav P, Gilchrist IC, Kozak M, Stebbins A, et al. Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2017;10(20):2064–75. 21. Nguyen TC, Babaliaros VC, Razavi SA, Kilgo PD, Guyton RA, Devireddy CM, et al. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2013;146(6):1399–406. 22. Van Linden A, Kempfert J, Rastan AJ, Holzhey D, Blumenstein J, Schuler G, et al. Risk of acute kidney injury after minimally invasive transapical aortic valve implantation in270patients.EurJCardio-thoracicSurg.2011;39(6):835–43. 23. Bagur R, Webb JG, Nietlispach F, Dumont É, De Larochellire R, Doyle D, et al. Acute kidney injury following transcatheter aortic valve implantation: Predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31(7):865–74. 24. Gargiulo G, Sannino A, Capodanno D, Trimarco C, Tamburino C, Esposito G. Impact of Postoperative Acute Kidney Injury on Clinical Outcomes after TAVI: a Meta-analysis of 5,971 patients. Catheter Cardiovasc Interv. 2015;86(3):518–27. 25. Mruk B. Renal Safety of Iodinated Contrast Media Depending on Their Osmolarity – Current Outlooks. Polish J Radiol [Internet]. 2016;81:157–65. 26. American College Radiology.(ACR).Committee on Drugs and Contrast Media. ACR Manual on Contrast Media. Version 10.3. Philadelphia;2018. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 1111